Webinar for the CIBRN community presented by all CIBRN Leaders Thurs, June 8, 9:00 pm EST

Please join the CIBRN Leaders for an in-depth, cross-discipline discussion of CIBRN 2017 Question #1, Question #2 & Question #3 surrounding the implications of the evolving biosimilar landscape on clinical practice and patient health in Canada.

This webinar is intended for the ALL CIBRN members and is scheduled for Thursday, June 8th, 9:00-10:00 pm ESTWebinar connection details will follow by email.

Prior to the webinar, you are invited to visit the CIBRN community on Sosido to review the questions & responses and to reply with your personal clinical perspectives:

The webinar will be recorded and archived for future viewing by the CIBRN community.

If you have any comments or questions, please contact me at your convenience.

Paul Abbass
LEGITIMED INC.
Email: paul.abbass@legitimed.com

—————-

If you have never attended an Adobe Connect meeting before:

Test your connection: https://studio7communications.adobeconnect.com/common/help/en/support/meeting_test.htm

Get a quick overview: http://www.adobe.com/products/adobeconnect.html